These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19435712)

  • 41. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
    Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
    Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia.
    Bär KJ; Franke S; Wenda B; Müller S; Kientsch-Engel R; Stein G; Sauer H
    Neurobiol Aging; 2003; 24(2):333-8. PubMed ID: 12498967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
    Foroumandi E; Alizadeh M; Kheirouri S; Asghari Jafarabadi M
    PLoS One; 2019; 14(3):e0213307. PubMed ID: 30856212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes care in Germany (JEVIN).
    Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Müller UA; Stein G
    Eur J Med Res; 2004 Aug; 9(8):391-9. PubMed ID: 15337629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
    Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
    Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.
    van Eupen MG; Schram MT; Colhoun HM; Scheijen JL; Stehouwer CD; Schalkwijk CG
    Cardiovasc Diabetol; 2013 Oct; 12():149. PubMed ID: 24134530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
    Koyama Y; Takeishi Y; Arimoto T; Niizeki T; Shishido T; Takahashi H; Nozaki N; Hirono O; Tsunoda Y; Nitobe J; Watanabe T; Kubota I
    J Card Fail; 2007 Apr; 13(3):199-206. PubMed ID: 17448417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
    Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
    J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
    Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
    Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
    Teerlink T; Barto R; Ten Brink HJ; Schalkwijk CG
    Clin Chem; 2004 Jul; 50(7):1222-8. PubMed ID: 15131022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pentosidine - a new biochemical marker in diabetic retinopathy.
    Salman AG; Mansour DE; Swelem AH; Al-Zawahary WM; Radwan AA
    Ophthalmic Res; 2009; 42(2):96-8. PubMed ID: 19546600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
    Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
    J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN).
    Schiel R; Franke S; Appel T; Voigt U; Ross IS; Kientsch-Engel R; Stein G; Müller UA
    J Diabetes Complications; 2003; 17(2):90-7. PubMed ID: 12614975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.
    Saeki C; Saito M; Kanai T; Nakano M; Oikawa T; Torisu Y; Saruta M; Tsubota A
    PLoS One; 2021; 16(4):e0249728. PubMed ID: 33798236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum pentosidine as an indicator of Alzheimer's disease.
    Meli M; Perier C; Ferron C; Parssegny F; Denis C; Gonthier R; Laurent B; Reynaud E; Frey J; Chamson A
    J Alzheimers Dis; 2002 Apr; 4(2):93-6. PubMed ID: 12214132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.